Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.7 |
mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.7 |
mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |